Multisubstrate Inhibitors of Histone Acetylation Increase the Cytotoxicity of Chemotherapeutic Agents

Inhibitors of histone acetylation may constitute a novel class of potent therapy sensitizers applicable to a broad range of conventional cancer treatments.

Inventors: 

Joseph Parello
Ruth Anne Gjerset
Keya Bandyopadhyay
Jean-Louis Baneras
Aimee Martin
Paul Reid
Casimir Blonski

Licensing manager: 
Mike Villalobos

Featured Video

CTTC: Moving Innovation Forward.

To watch more videos like this one, visit CTTC's YouTube Channel.

CTTC on Twitter